Statistics
Publications
38
Citations
1.7K
H-Index
22
Active since
1999
Luke Boulanger is an author at Eli Lilly (United States) specializing in pharmacoeconomics, pharmacy, and pharmacotherapy.
Publications per year
1999–2022
38
38
Potential Short-Term Economic Benefits of Improved Glycemic Control
Joseph Menzin, Clare Langley-Hawthorne, Mark Friedman et al. · Diabetes Care · 2001 · 177 citations · Full text
Luke Boulanger, Ji Soo Kim, Mark Friedman et al. · International Journal of Clinical Practice · 2006 · 94 citations
1–5 of 38